Long-term Maintenance of Remission with No Dose Escalation Aft er Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 3-year Results from the PRECiSE 4 Study

被引：0
|
作者：
Sandborn, William [1 ]
Schreiber, Stefan [2 ]
Hanauer, Stephen [3 ]
Colombel, Jean-Frederick [4 ]
Bloomfield, Ralph [5 ]
Lichtenstein, Gary [6 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Kiel, Kiel, Germany
[3] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[4] Hop Claude Huriez, Lille, France
[5] UCB Pharma, Slough, Berks, England
[6] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1207
引用
收藏
页码：S448 / S448
页数：1
相关论文
共 50 条
  • [31] Long-Term Remission With Certolizumab Pegol in Crohn's Disease: Efficacy Over 5 Years in Patients With No Prior Anti-TNF Agent Exposure (PRECiSE 3 Study)
    Sandborn, William J.
    Schwartz, David A.
    Schreiber, Stefan
    Lawrance, Ian C.
    Sen, David I.
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S262 - S262
  • [32] Long-term remission with certolizumab pegol in Crohn's disease: Efficacy over 5 years in patients with no prior anti-TNF agent exposure (precise 3 study)
    Sandborn, William J.
    Schwartz, David
    Schreiber, Stefan
    Lawrance, Ian C.
    Sen, David
    Lichtenstein, Gary R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S23 - S23
  • [33] Regain of Response and Remission by Dose Adjustment in Patients with Crohn's Disease Who Responded to Certolizumab Pegol: Results from the WELCOME Study
    Sandborn, William
    D'Haens, Geert
    Vermeire, Severine
    Colombel, Jean-Frederick
    Fedorak, Richard
    Spehlmann, Martina
    Wolf, Douglas
    Mitchev, Krassimir
    Jamoul, Corinne
    Abreu, Maria
    Rutgeerts, Paul
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S450 - S451
  • [34] Long-Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohn's Disease: 5-Year Results
    Ptak, Theadore
    Younes, Ziad
    Shafran, Ira
    Lee, Scott
    Miner, Philip B.
    Kayhan, Cem
    Kosutic, Gordana
    Coarse, Jason
    Hasan, Iram
    Spearman, Marshall
    Sandborn, William J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S774 - S775
  • [35] Prior Use of Infliximab As a Predictor of Long-Term Outcomes of Treatment With Certolizumab Pegol for Active Crohn's Disease: Analyses From the Precise 3 7-Year Study
    Rubin, David T.
    Coarse, Jason
    Kosutic, Gordana
    Spearman, Marshall
    Ambarkhane, Sumeet
    Jojic, Njegica
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S249 - S249
  • [36] Fecal Calprotectin Concentration and Clinical Remission in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: Results from PRECiSE 1
    Sandborn, William
    Ullman, Thomas
    Pierre-Louis, Bosny
    Binion, David
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S441 - S441
  • [37] Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter Study
    van der Heijde, Desiree
    Gensler, Lianne
    Maksymowych, Walter
    Landewe, Robert
    Rudwaleit, Martin
    Bauer, Lars
    Hoepken, Bengt
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1896 - 1899
  • [38] Higher remission and maintenance of response rates with subcutaneous monthly certolizumab pegol in patients with recent-onset Crohn's disease:: Data from PRECiSE 2
    Sandborn, William J.
    Colombel, Jean-Frederic
    Panes, Julian
    Schoelmerich, Juergen
    McColm, Juliet A.
    Schreiber, Stefan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S434 - S435
  • [39] Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world study
    Hisamatsu, Tadakazu
    Suzuki, Yasuo
    Kobayashi, Mariko
    Hagiwara, Takashi
    Kawaberi, Takeshi
    Ogata, Haruhiko
    Matsui, Toshiyuki
    Watanabe, Mamoru
    Hibi, Toshifumi
    [J]. INTESTINAL RESEARCH, 2021, 19 (04) : 408 - 418
  • [40] Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Schreiber, Stefan
    Randall, Charles W.
    Regueiro, Miguel
    Ali, Tauseef
    Arendt, Catherine
    Coarse, Jason
    Spearman, Marshall
    Kosutic, Gordana
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (12) : 1753 - 1762
12345